静脉注射钴宾酰胺与羟钴胺或生理盐水治疗猪严重硫化氢中毒的疗效比较
该研究为猪(Sus scrofa)模型实验,比较静脉注射钴宾酰胺(4 mg/kg,溶于0.8 mL 225 mmol/L溶液)、羟钴胺(4 mg/kg,溶于5 mL生理盐水)或单用生理盐水对急性硫化氢诱导呼吸暂停的治疗反应,主要终点为恢复自主通气时间。24头猪(45-55 kg)在麻醉插管并持续监测下,以硫氢化钠(8 mg/mL)1 mg/kg/min输注至呼吸暂停确认20秒后继续1.5分钟,随后降至维持速率,随机分组后从呼吸暂停后1分钟开始监测60分钟。钴宾酰胺组8/8存活,对照组0/8、羟钴胺组0/8存活;钴宾酰胺组恢复自主通气平均时间为3.2(±1.1)分钟。结论认为钴宾酰胺在无辅助通气条件下成功使严重硫氢化钠中毒猪从呼吸暂停中获救。
要点
- 在硫化氢诱导呼吸暂停的猪模型中,钴宾酰胺4 mg/kg静脉注射使8/8动物恢复自主呼吸并存活,羟钴胺4 mg/kg组和生理盐水组均为0/8存活。
- 钴宾酰胺组恢复自主通气的平均(±SD)时间为3.2(±1.1)分钟,监测从呼吸暂停后1分钟开始,持续60分钟。
- 三组产生呼吸暂停所需的硫氢化钠剂量无显著差异(5.6 mg/kg;p=0.45),基线变量也无显著差异。
- 该研究为动物模型,钴宾酰胺的疗效尚未在人类硫化氢中毒中验证。
适用人群与场景
- 麻醉、插管并持续监测股动脉和肺动脉压力的猪(45-55 kg),经硫氢化钠输注诱导呼吸暂停的急性硫化氢中毒模型。
诊断标准与关键阈值
- 以二氧化碳波形图确认呼吸暂停持续20秒作为中毒终点,硫氢化钠输注速率1 mg/kg/min。
处置流程与药物剂量
- 硫氢化钠(浓度8 mg/mL)以1 mg/kg/min开始输注,呼吸暂停确认后继续该速率1.5分钟,随后降至维持速率至研究结束。
- 呼吸暂停后随机给予静脉注射钴宾酰胺4 mg/kg(溶于0.8 mL 225 mmol/L溶液)、羟钴胺4 mg/kg(溶于5 mL生理盐水)或单用生理盐水。
- 从呼吸暂停后1分钟开始监测60分钟,观察恢复自主通气情况。
研究设计与关键结果
- 研究类型为动物模型实验,样本量24头猪(45-55 kg),随机分为钴宾酰胺组、羟钴胺组和生理盐水组,每组8头。
- 主要终点为恢复自主通气时间:钴宾酰胺组8/8存活并恢复自主通气,平均(±SD)时间3.2(±1.1)分钟;羟钴胺组0/8存活,生理盐水组0/8存活。
- 三组产生呼吸暂停的硫氢化钠剂量无显著差异(5.6 mg/kg;p=0.45),基线变量无显著差异。
证据类型、等级与局限
- 证据类型:动物实验(猪模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为钴宾酰胺在无辅助通气条件下成功使严重硫氢化钠中毒猪从呼吸暂停中获救,该结果来自动物模型,尚未在人类中验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hydrogen sulfide (H2 S) is a potentially deadly gas that naturally occurs in petroleum and natural gas. The Occupational Health and Safety Administration cites H2 S as a leading cause of workplace gas inhalation deaths. Mass casualties of H2 S toxicity may be caused by exposure from industrial accidents or release from oil field sites. H2 S is also an attractive terrorism tool because of its high toxicity and ease with which it can be produced. Several potential antidotes have been proposed for hydrogen sulfide poisoning but none have been completely successful.
OBJECTIVE: The objective was to compare treatment response assessed by the time to spontaneous ventilation among groups of swine with acute H2 S-induced apnea treated with intravenous (IV) cobinamide (4 mg/kg in 0.8 mL of 225 mmol/L solution), IV hydroxocobalamin (4 mg/kg in 5 mL of saline), or saline alone.
METHODS: Twenty-four swine (45-55 kg) were anesthetized, intubated, and instrumented with continuous femoral and pulmonary artery pressure monitoring. After stabilization, anesthesia was adjusted such that animals would spontaneously ventilate with an FiO2 of 0.21. Sodium hydrosulfide (NaHS; concentration of 8 mg/mL) was begun at 1 mg/kg/min until apnea was confirmed for 20 seconds by capnography. This infusion rate was sustained for 1.5 minutes postapnea and then decreased to a maintenance rate for the remainder of the study to replicate sustained clinical exposure. Animals were randomly assigned to receive cobinamide (4 mg/kg), hydroxocobalamin (4 mg/kg), or saline and monitored for 60 minutes beginning 1 minute postapnea. G* power analysis using the Z-test determined that equal group sizes of eight animals were needed to achieve a power of 80% in detecting a 50% difference in return to spontaneous ventilations at α = 0.05.
RESULTS: There were no significant differences in baseline variables. Moreover, there were no significant differences in the mg/kg dose of NaHS (5.6 mg/kg; p = 0.45) required to produce apnea. Whereas all of the cobinamide-treated animals survived (8/8), none of the control (0/8) or hydroxocobalamin (0/8)-treated animals survived. Mean (±SD) time to spontaneous ventilation in the cobinamide-treated animals was 3.2 (±1.1) minutes.
CONCLUSIONS: Cobinamide successfully rescued the severely NaHS-poisoned swine from apnea in the absence of assisted ventilation.
参考来源
- Bebarta VS, Garrett N, Brenner M, et al. Efficacy of Intravenous Cobinamide Versus Hydroxocobalamin or Saline for Treatment of Severe Hydrogen Sulfide Toxicity in a Swine (Sus scrofa) Model. Acad Emerg Med. 2017. PMID: 28472554. doi:10.1111/acem.13213
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。